13 filings
8-K
AKCA
Akcea Therapeutics, Inc.
19 Dec 19
Other Events
7:00am
8-K
AKCA
Akcea Therapeutics, Inc.
16 Dec 19
Akcea Therapeutics Announces New Appointments to its Board of Directors
4:15pm
8-K
AKCA
Akcea Therapeutics, Inc.
4 Dec 19
Akcea Announces Appointment of New Chief Operating Officer
7:30am
8-K
AKCA
Akcea Therapeutics, Inc.
5 Nov 19
Akcea Reports Financial Results and Highlights for Third Quarter 2019
12:00am
8-K
AKCA
Akcea Therapeutics, Inc.
23 Oct 19
Akcea Announces Appointment of New Chief Commercial Officer
7:30am
8-K
kaag iopppg8
17 Oct 19
Entry into a Material Definitive Agreement
4:16pm
8-K
vopyo zqgx8
8 Oct 19
Akcea and Pfizer Inc. Announce Licensing Agreement for Akcea and Ionis to earn $250 million license fee
4:16pm
8-K
cmkc77 vcub9mnp4
23 Sep 19
Akcea Announces CEO Transition and Elects Two New Board Members
7:15am
8-K
f2m026atwjg608yz5fg9
6 Aug 19
Akcea Reports Financial Results and Highlights for Second Quarter 2019
4:16pm
8-K
im3x4h3gv4
8 May 19
Akcea Reports Financial Results and Highlights for First Quarter 2019
4:16pm
8-K
ec9yd4n sd
26 Apr 19
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
4j54 unmba6
26 Feb 19
Akcea Reports Financial Results and Highlights for Fourth
4:16pm
8-K
7gwa2pmps ba
25 Feb 19
Entry into a Material Definitive Agreement
6:06am
- Prev
- 1
- Next